Melioidosis: A new target identified to combat a dangerous bacterial infection

Researchers at the Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Leibniz-HKI) in Jena, Germany have identified an enzyme that is a promising new therapeutic target to combat the dangerous bacterial disease melioidosis. It helps the pathogenic bacterium Burkholderia pseudomallei construct a toxic molecule that is critical in the infection process. The results were published in Nature Chemistry.

Quelle: IDW Informationsdienst Wissenschaft